US › Healthcare

Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

US · Healthcare · Biotechnology

$46.52+3.38%

Last close · 2026-08-04

Key statistics

Market cap

$2.09B

Forward P/E

0.0

P/B

0.00

Book value

$-209.96

EPS (TTM)

$-9.59

52-week high

$52.15

52-week low

$18.00

50-day MA

$33.43

200-day MA

$32.26

Analyst view

with an average price target of $50.00.

Shareholding

Insiders

10.78%

Institutions

70.26%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Hemab Therapeutics Holdings, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.